Abbreviation used: NMDA, N-methyl-D-aspartate. 109 ± 17 110 ± 18 121 ± 30 102 ± 22
Summary:
In contrast to intraischemic hypothermia, im mediate postischemic hypothermia (30°C) has been shown to delay but not chronically protect the CAl hip pocampus from transient global forebrain ischemia. The inability of a relatively short postischemic hypothermic period to protect chronically might involve a delayed or secondary injury mechanism. We determined whether de layed treatment with the noncompetitive N-methyl-D aspartate receptor antagonist MK-801 (dizocilpine), alone or in combination with immediate post ischemic hypother mia, would chronically protect histopathologically. Wi star rats underwent 10 min of normothermic forebrain ischemia induced by bilateral common carotid artery oc clusion plus hypotension (50 mg Hg). Four ischemia groups were studied after normothermic (37°C) ischemia: no treatment; 3 h of immediate postischemic hypothermia (30°C); delayed MK-801 treatment (4 mg/kg) on postisch emic days 3, 5, and 7; and postischemic hypothermia combined with multiple MK-801 treatments. Two months after the ischemic insult, rats were perfusion-fixed for quantitative histopathological assessment. Postischemic hypothermia alone or MK-801 treatment alone failed to protect the CAl hippocampus chronically. However, im mediate postischemic hypothermia combined with de-While intraischemic hypothermia has been shown to reduce chronically the neurobehavioral and his topathological consequences of transient forebrain ischemia (Green et aI., 1993) , recent investigations layed MK-801 treatment led to significant increases in normal CAl neuron counts per microscopic field com pared with normothermic ischemia. For example, neuro nal counts within the hippocampal CAl areas were 58 ± 39 (mean ± SD) in normothermic ischemic rats compared with 395 ± 198 in rats treated with postischemic hypo thermia and MK-801. Chronic survival also led to pro nounced striatal damage. Within the dorsolateral stria tum, significant protection was documented with either postischemic hypothermia alone or delayed MK-801 treatment alone. In the striatum, neuronal counts were 8 ± 5, 47 ± 29, and 63 ± 30 in normothermic, MK-801treated, and postischemic hypothermic rats, respectively. Significant protection within the somatosensory cortex was not observed with any of the treatment protocols. These findings indicate that the post ischemic hippocam pus and striatum undergo a delayed excitotoxic insult as late as postischemic day 3. Based on chronic histopatho logical assessment, the therapeutic window for striatal neuroprotection after a brief global ischemic insult ap pears to be longer than previously appreciated. Key Words: Excitotoxicity-Hypothermia-Ischemia Microglia-N europrotection-Secondary injury.
have reported the inability of restricted periods of postischemic hypothermia to protect the CAl hip pocampus chronically (Dietrich et aI., 1993; Col bourne and Corbett, 1994b) . In one study, 3 h of immediate postischemic hypothermia (30°C) follow ing a IO-min normothermic ischemic insult was re ported to provide neuroprotection of the CAl hip pocampus at 3 and 7 days postischemia but not at 2 months (Dietrich et aI., 1993) . These findings are supported by histopathological data in gerbils that also indicate progressive neuronal death after 30 days following transient global ischemia (Colbourne and Corbett, 1994b) . Together, these data empha size the need for chronic survival studies when ulti mate histopathological outcome following poten tially therapeutic protocols is investigated.
The inability of a 3-h period of postischemic cool ing to protect the CAl hippocampus chronically may be a consequence of various postischemic pathomechanisms. First, in contrast to intra ischemic hypothermia, postischemic hypothermia may only be slowing the ischemic maturation pro cess so that longer survival periods are required to visualize the damaged neurons morphologically. In this regard, Morse and Davis (1990) have shown in gerbils that adrenalectomy, which causes a drop in body and brain temperature, slows down ischemic cell death in the hippocampus. Thus, it is possible that ischemia-induced excitotoxic processes with subsequent activation of second messenger sys tems, as well as other ischemic processes, could be de pressed but not inhibited by postischemic hypo thermia (Dietrich et al., 1995) .
An alternative explanation for the failure of post ischemic hypothermia to protect chronically is that the partially protected postischemic brain under goes a delayed secondary insult. In this regard, mi croglial cell accumulation within the postischemic CAl hippocampus has been reported (Morioka et al., 1991; Gehrmann et al., 1992a,b; Dietrich et al., 1993) . With use of immu�lOcytochemical tech niques, microglial activation was shown to be par ticularly prominent between 3 and 7 days after tran sient global ischemia (Gehrmann et al., 1992a,b) . In another study, microglial accumulation within the damaged CAl hippocampus was examined ultra structurally at 7 days after postischemic hypother mia (Dietrich et al., 1993) . Interestingly, activated microglial cells were seen in close proximity to vi able neuronal cell bodies. Such an anatomical rela tionship might suggest that deleterious substances released by activated microglial cells could poten tially affect chronic neuronal survival within the partially protected region.
Microglial cells generate and release a variety of substances including cytokines, oxygen radicals, and proteases, as well as excitatory amino acids (Giulian, 1987; Banati et al., 1991; Piani et al., 1991; Boje and Arora, 1992; Chao et al., 1992) . In a study of spinal contusion injury, regional increases in the N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid correlated with activation and increased density of microglia and macrophages starting 3 days after injury (Pop ovich et al., 1993) . In a cell culture study, neuro toxicity elicited by microglial cell-derived mole-cules was shown to be blocked by the noncompet itive NMDA antagonist MK-801 (Piani et al., 1991) .
Thus, in the postischemic setting in which thera peutic manipulations may lead to only partial pro tection, activated microglial cells may potentially result in secondary injury processes involving ex cessive NMDA receptor activation. Since global ischemia has been reported to induce a switch in CAl glutamate receptor subunits, the susceptibility of the postischemic brain to delayed excitotoxic processes might also be increased (Pellegrini Giampietro et al., 1992) .
The primary goal of this study was to determine whether delayed MK-801 treatment alone or in combination with immediate postischemic hypo thermia would lead to chronic histopathological protection following transient global ischemia.
Thus, MK-801 treatment was initiated at 3 days fol lowing the ischemic insult and continued until day 7, a postischemic period corresponding to maxi mum microglial activation within the CAl hippo campus (Gehrmann et al., 1992a) . Since preliminary data indicate that in chronic survival studies the dorsolateral striatum and parietal cortex are also damaged, those regions were investigated also.
MATERIALS AND METHODS

Animal preparation
These experiments were conducted on 30 fasted male Wi star rats (Charles River) weighing between 250 and 300 g. Rats were initially anesthetized with 3% halothane/30% oxygen/balance nitrous oxide. Femoral arteries and veins were cannulated with PE-50 tubing. The common carotid arteries were exposed bilaterally in the neck, and close fitting PE tubing contained within another dual-bore Si las tic tubing was looped around each carotid artery. An imals next underwent intubation with PE-240 tubing in serted with the aid of a metal guide. Prior to intubation, atropine (0.15 mg/kg i. p.) was given to diminish secre tions. Animals were then immobilized with pancuronium bromide (0.75 mg/kg i. v. ) and maintained with repeated doses of 0. 35 mg/kg i.v. every 30 min. They were con nected to a rodent respirator (Stoelting) and ventilated on a mixture of 70% nitrous oxide/2% halothanelbalance ox ygen that was passed through a humidifier containing 5% Mucomyst-IO and water. Animals were then stabilized for a period of 15 min, during which arterial blood gases were measured and controlled at normal levels by adjusting the respirator. To directly monitor brain temperature, a 33gauge thermocouple probe was placed in the right stria tum of all rats. Rectal temperature was also monitored and controlled between 36.5 and 37°C throughout the ex perimental protocol by a heating lamp positioned over the animal. Brain temperature was independently adjusted by manipulating the height of a small high-intensity lamp placed above the head. In the experiments in which post ischemic hypothermia was required, a decrease in brain temperature was induced by blowing cool air onto the surface of the head by a high speed fan.
Production of cerebral ischemia
Anesthetized animals were prepared for bilateral com mon carotid artery occlusion combined with systemic hy potension (50 mm Hg). Mean arterial blood pressure was lowered to �60 mm Hg and the ischemic insult initiated by tightening the carotid ligatures bilaterally. Blood was withdrawn until arterial blood pressure declined to 50 mm Hg; the onset of the 10-min ischemic insult was timed from that point. During the ischemic insult, respiration was adjusted by decreasing respiratory volume rates so as to maintain arterial P02 close to the normal value. Halo thane anesthesia (I %) was maintained throughout the ischemic period. The ischemic insult was terminated by loosening the carotid ligatures and slowly reinfusing the shed blood (maintained at 36-37°C) to restore normoten sion. At this time, ventilation was adjusted to normalize arterial blood gases. Full physiological monitoring was continued for 3 h into the postischemic period. Arterial and venous catheters were then removed with appropri ate caution and all wounds infiltrated with I % lidocaine; cephazolin (Kefzoi) 20 mg/kg was injected intravenously. Rats were then placed in a recuperation chamber at room temperature with free access to water and food pellets.
Experimental groups
Experimental animals were randomized into five sub groups, each containing five to eight animals. In the nor mothermic series, intraischemic and postischemic brain temperatures were maintained at 36.5-37°C during the 3-h observational period. In the postischemic hypothermic series, rats underwent normothermic ischemia followed by a 3-h hypothermic period (29.5-30°C); this moderate level of brain hypothermia was achieved between 3 and 5 min into the recirculation period. In normothermic isch emic animals that were treated with MK-801 (4 mg/kg i. p.), treatment was initiated on postischemic days 3, 5, and 7. In previous studies, MK-801 treatment in intact rats has been shown to produce an acute heterogeneous pattern of altered glucose utilization including hyperme tabolism followed by widespread metabolic depression at 24 h (Dietrich et aI., 1989; Kurumaji and McCulloch, 1989) . In the postischemic hypothermic series in which animals received MK-801, similar multiple injections of MK-801 on days 3, 5, and 7 were administered. To deter mine the consequences of MK-801 treatment on core tem perature, rectal temperature readings were recorded in awake rats 5-10 min prior to treatment and for up to 5 h after each injection. During these measurements, ambient temperature in the laboratory ranged between 21.7 and 22.2°C. Sham-operated control animals underwent brain temperature measurements and all surgical procedures except the induction of brain ischemia. All rats were be haviorally tested prior to histopathological analysis. The neurobehavioral findings have been recently published in abstract form (Mayberry et aI., 1994) and are the topic of another report (E. J. Green et aI., in preparation) .
Light microscopic histopathology
At 2 months after the ischemic insult, rats were re anesthetized with halothane and perfusion-fixed via the ascending aorta with FAM, a mixture of 40% formalde hyde, glacial acetic acid, and methanol (1: 1:8 by vol), for 20 min at a pressure of 100-110 mm Hg following a I-min initial perfusion with physiological saline. Heads were im mersed in F AM at 4°C for 1 day. Brains were then re moved and divided into coronal blocks that were embed ded in paraffin. Brain sections 10 j.1m thick were prepared at 250-j.1m intervals. They were stained with hematoxylin and eosin. The intensity of the ischemic injury within the hippocampus was quantitated by an observer who was blinded to the experimental protocol by counting num bers of normal-appearing pyramidal neurons per high power field (400x) in the lateral, middle, and medial sub sectors of the hippocampal CAl region at five rostrocau dal levels of the hippocampus. These five levels corre sponded roughly to 2. 3, 3. 3, 4. 3, 4. 8, and 5.8 mm poste rior to bregma (Zilles, 1995) . Viable neurons were defined as those cells showing a distinct nucleus and nucleolus. This particular microscopic field corresponded to an � 375-j.1m length of pyramidal neurons. Numbers of nor mal neurons were also quantitated by counting cells in the dorsolateral striatum (400x) and in layer III and IV of the neocortex centered at --<-2 mm dorsal to the entorhinal fissure (400x).
Statistical analysis
Data are expressed as means ± SD. Normal cell counts in hippocampus CAl sub sectors were assessed with one way and two-way analysis of variance (including repeated measures when required) by SAS general linear models routines (SAS Institute, Cary, NC, U.S.A.). Differences were regarded as statistically significant at p < 0.05. Table 1 summarizes the physiological variables.
RESULTS
Arterial blood gases and mean arterial blood pres sure prior to and following ischemia were generally within the normal range and were similar in the dif ferent experimental groups. To determine whether the administration of MK-801 led to alterations in core temperature, rectal temperature measure ments were made up to 5 h after each MK-801 in jection. As shown in Table 2 , MK-801 treatment did not significantly alter rectal temperatures. How- 
First injection (day 3) Second injection (day 5)
Third injection (day 7)
36.8 ± 0. 3 36.8 ± 0. 3 36. 8 ± 0. 4 37. 7 ± 0. 6 37.8 ± 0. 7 37. 5 ± 0. 7 37. 6 ± 0. 9 37. 6 ± 0. 9 37. 7 ± 0. 9 37. 3 ± 0.9 37. 0 ± 0. 3 37.8 ± 0. 3 37.7 ± 0. 6 37.5 ± 0. 6 37.4 ± 0. 7 37. 4 ± 0.7 37.8 ± 0. 4 37. 8 ± 0. 4 37. 8 ± 0. 4 37. 5 ± 0. 7 37. 0 ± 0. 3
Values are means ± SD. ever, rectal temperatures were consistently ele vated compared with baseline values. Figure I shows representative light microscopic changes within the CAl hippocampus for the vari ous experimental groups. Two months after 10 min of normothermic ischemia, few viable neurons were observed within the CAl hippocampus (Fig. IA) . Postischcmic hypothermia alone (Fig. IB) However, in the group where immediate postisch emic hypothermia was combined with delayed MK-801 treatment, moderate numbers of viable neurons were seen within the damaged CAl sectors (Fig.  ID) . In these rats, isolated as well as small groups of viable neurons were observed within the CAl sector.
Quantitative cell counts of viable neurons dem onstrated that normothermic ischemia reduced cell counts to only 5% of sham-operated control values (Fig. 2) . In ischemic rats treated with hypothermia plus MK-801, a significant increase in normal neu ronal counts compared with the normothermic group was seen (Fig. 2) . The combined treatment represented a six-to sevenfold increase in normal neuron counts compared with normothermic isch emia. In contrast, no significant differences be tween the normothermic groups and the individual treatments alone were documented. All ischemic groups were significantly different from sham con trols.
Ten minutes of normothermic ischemia led to consistent damage to the dorsolateral striatum ( values, normothermic ischemia led to a 90% loss of normal-appearing neurons in the dorsolateral stria tum (Fig. 4) . Immediate postischemic hypothermia alone (Fig. 3B) , delayed MK-801 treatment alone (Fig. 3C) , as well as the combination Qf hypother mia plus MK-801 ( Fig. 3D) ,all led to protection of the dorsolateral striatum. Individual cell counts of viable neurons within the dorsolateral striatum demonstrated significant increases in neurons within the MK-801 group (47 ± 29, mean ± SD), postischemic hypothermia group (63 ± 30), as well as the combined treatment group (86 ± 10) com pared with normothermic ischemia (8 ± 5) ( Fig. 4) . A significant decrease in viable neurons (62% of control) within layers III and IV of the cerebral cor tex was shown 2 months after normothermic isch emia. Although hypothermia, MK-801 treatment, as well as hypothermia plus MK-801 treatment led to greater numbers of viable neurons compared with normothermic ischemia, these differences were not significant (Fig. 5) . However, only the neuronal cell counts obtained from the normothermic ischemic group were shown to be significantly different from those in the sham-operated control group.
DISCUSSION
In this study, the consequences of immediate postischemic hypothermia with or without delayed MK-801 treatment were assessed 2 months after the ischemic injury. Recent data from our laboratory as well as others have emphasized the need for chronic survival when assessing the beneficial effects of postischemic hypothermia (Dietrich et aI., 1993; Colbourne and Corbett, 1994a,b) . For example, we have shown that although immediate postischemic hypothermia of a 3-h duration led to significant pro tection early, no protection was seen at 2 months (Dietrich et aI., 1994) . More recently, Colbourne and Corbett (l994a) have reported in gerbils that postischemic hypothermia (32°C) for 24 h begun 1 h after 5 min of normothermic ischemia leads to near total preservation of CAl neurons at 30 days. How ever, in a more recent study, the same authors dem onstrated that numbers of viable neurons declined after the I-month survival period (Colbourne and Corbett, 1994b) . Thus, in regard to postischemic hypothermic protection, experimental variables, in cluding when postischemic hypothermia is initiated, its duration and level, as well as the survival period, are all important when assessing hypothermic neu roprotection.
Our data demonstrate that immediate postisch emic hypothermia combined with delayed MK-801 treatment leads to significant protection of the CAl hippocampus. Since MK-801 treatment was initi ated at 3 days after the ischemic insult, these results indicate that the CAl hippocampus may undergo a delayed excitotoxic injury process. As previously discussed, one potential source of excitatory amino acids in this late recirculation period is activated microglia (Piani et aI., 1991; Popovich et aI., 1993 ). The present results do not, however, imply that other cell types (i.e., astrocytes) or other ischemic processes (reactive oxygen species or nitric oxide radical) may also be involved in this injury process. For example, since NMDA receptor activation leads to acute microvascular perturbations (Diet rich et ai., 1992) , delayed MK-801 treatment might also be affecting vascular events including reperfu sion injury. To determine critically whether acti vated microglia or invading macrophages are re sponsible for delayed cell death after postischemic hypothermia, additional experiments are required in which macrophage accumulation is pharmacolog ically reduced (Giulian and Robertson, 1990; Chopp et ai., 1994) . Although early studies of global isch emia reported neuroprotection with early postisch emic MK-801 treatment (Gill et ai., 1988; Rod and Auer, 1992) , more recent studies have failed to demonstrate histopathological protection (Nellgard et ai., 1991; Nellgard and Wieloch, 1992) . The fact that, in this study, delayed MK-801 treatment alone failed to provide protection of the CAl hippocam pus indicates that one beneficial effect of postisch emic hypothermia is to delay the onset of irrevers ible neuronal injury, thereby extending the thera peutic window for secondary pharmacotherapy.
In gerbils, the protective effects of MK-801 have been largely attributed to drug-induced hypother mia (Buchan and Pulsinelli, 1990; Corbett et aI., 1990) . In the present study, MK-801-induced hypo thermia during the late reperfusion period may therefore have contributed to the beneficial effects of repeated MK-801 treatments. Although measure ments of rectal temperature did not demonstrate a hypothermic response to MK-801 treatment, our method of obtaining core temperature readings in awake rats is not optimal. In future studies, it will be necessary to monitor core as well as brain tem perature telemetrically (Uchino et aI., 1994) to de termine the temperature effects of multiple MK-801 injections in the postischemic setting.
Pharmacotherapy in conjunction with hypother mia has been shown to have a beneficial effect on brain protection. Hypothermia combined with bar biturates is known to have an additive effect on reducing cerebral blood flow and oxygen consump tion (Nordstrom and Rehncrona, 1978) . Ikonomi dou and colleagues (1989) have shown that hypo thermia enhances the protective effect of MK-801 against hypoxic-ischemic brain damage in infant rats. In the setting of transient forebrain ischemia, the combination of nimodipine and MK-801 begun 20 min after ischemia was reported to lead to pro tection of the neocortex, striatum, and temporal hippocampus (Rod and Auer, 1992) . Ginsberg and J Cereb Blood Flow Metab, Vol. 15, No.6, 1995 colleagues (1990) have also reported that combined therapy with hypothermia plus dextromethorphan protected the neocortex from injury in excess of the protection conferred by either hypothermia or dex tromethorphan alone. Unlike previous studies, hy pothermia and MK-801 treatments were given at different postischemic periods in the present study. These findings emphasize that the progression of ischemic damage with postischemic hypothermia involves multiple, temporally specific pathomecha nisms. Thus, in the treatment of ischemic brain in jury and stroke, successful treatment protocols may potentially involve several classes of agents, di rected by pathway-specific treatment windows oc curring over extended postinjury periods (Dietrich et aI., 1994) .
Another new finding of this study was that even following a relatively brief 10-min ischemic insult, consistent damage was seen in the dorsolateral stri atum at 2 months. Although the dorsolateral stria tum is considered a selectively vulnerable brain region after prolonged periods of transient fore brain ischemia (Pulsinelli et aI., 1982) , relatively brief periods of global ischemia have been reported to result in 6nly mild and inconsistent damage to the striatum (Lin et aI., 1990; Rod and Auer, 1992) . In previous studies, however, relatively short survival periods were investigated. In this regard, Nakano and colleagues (1990) have described in the rat a type of progressive neuronal damage in the dorso lateral striatum and cerebral cortex that evolves over several weeks following transient middle ce rebral artery occlusion. The temporal profile of delayed ischemic cell injury after transient global ischemia may therefore be dependent on the isch emic duration, with chronic survival periods being necessary to visualize the final pathological re sponse.
In the striatum, immediate postischemic hypo thermia, as well as delayed MK-801 treatment alone, significantly protected the striatum from ischemic damage. These results therefore differ from those reported in the CAl hippocampus, where neither treatment alone conveyed significant protection. The fact that hypothermia is known to affect multiple ischemic pathomechanisms (Dietrich e aI., 1995) , including excitotoxic injury (Busto et aI., 1989; Baker et ai., 1991; McDonald et aI., 1991; Mitani and Kataoka, 1991) , may indicate that both treatments are affecting excitotoxic processes. Re gardless of the exact pathomechanism, the ability to significantly protect the dorsolateral striatum by multiple MK-801 injections starting at 3 days after the ischemic insult indicates a relatively long ther apeutic window for neuroprotection.
Within the parietal neocortex, 10 min of global ischemia significantly reduced the number of nor mal-appearing neurons within layers III and IV.
This cortical region has previously been shown to be vulnerable to transient global ischemia (Lin et al., 1992; Nellgard and Wieloch, 1992; Pulsinelli et al., 1982) . Although each treatment protocol led to increased numbers of normal-appearing neurons compared with normothermic ischemia, these in creases were not significantly different from values in normothermia. However, the fact that significant differences existed between the sham-operated con trol rats and normothermic ischemic rats but not the other ischemic groups would indicate that each of the three postischemic treatments had some bene ficial effect. At present, it is not known whether cell counts from other cortical layers, including V and VI, might have shown greater degrees of neuropro tection.
In summary, the present results demonstrate that postischemic hypothermia in combination with delayed MK-801 treatment leads to chronic protec tion of the CAl hippocampus. These findings impli cate delayed excitotoxic processes in the failure of postischemic hypothermia to protect the CAl hip pocampus chronically. In other studies in which pharmacotherapy is initiated in the acute postisch emic setting, delayed treatments may also be nec essary to produce chronic protection. Within the striatum, our results show significant damage to the dorsolateral sector followi n g 10 min of ischemia when histopathological assessment is conducted at 2 months. These data also indicate a slow progres sive injury in the striatum that may involve second ary injury mechanisms. Taken together, these histopathological findings are consistent with the beneficial effects of combined postischemic hypo thermia and delayed MK-801 treatment on the neu robehavioral consequences of transient global isch emia (Mayberry et al., 1994) .
